Optum of New York, INC.

Optum of New York, INC. was paid $1.47M by Medicaid between Jan 2018 and Dec 2022, across 2 billing codes. Its largest line is S9560, Home injectable therapy; hormonal therapy (e.g.; leuprolide, goserelin), including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem — 80% of everything it billed.

Compared with peers

Next to other Home Health Agency providers in New York

Rank by total paid#675 of 851

Median peer was paid$15.00M

This provider vs. median0.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	2,712	$529K
2019	2,338	$469K
2020	46	$9K
2021	941	$207K
2022	1,037	$256K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
S9560	Home injectable therapy; hormonal therapy (e.g.; leuprolide, goserelin), including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem	80%	6,166	1,918	$1.18M
J1726	Injection, hydroxyprogesterone caproate, (makena), 10 mg	20%	908	313	$292K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRIGGINS-JONES, DARLENE (BILLING SUPERVISOR)